Clinical Research Directory
Browse clinical research sites, groups, and studies.
Safety and Tolerability of a Novel Implantable Device for the Treatment of Erectile Dysfunction
Sponsor: Comphya Australia
Summary
The goal of this clinical trial is to assess if a new device is safe to use as a potential treatment for erectile dysfunction following radical prostatectomy. The main questions it aims to answer are: * Is the device safe? * Does the device works well? Are the participants satisfied with the device? Participants will be implanted with the device during the ongoing prostatectomy surgery and will be asked to complete the following tasks during 6 months follow-up: * Come to the hospital for follow-up visits, * Complete questionnaires, * Activate the device every day, * Measure erection hardness. Researchers will compare an implanted group (participants having the device) with a control group (participants not having the device) to see if the device works well.
Official title: Safety and Tolerability of a Novel Implantable Device for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
Key Details
Gender
MALE
Age Range
30 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2023-05-19
Completion Date
2026-08-31
Last Updated
2026-03-18
Healthy Volunteers
No
Interventions
Activation of pro-erectile nerves within the pelvic plexus
The study device is an active implantable device. The device activates the cavernous nerves by delivering electrical pulses, to trigger an on-demand erection. The daily delivery of electrical pulses to the cavernous nerves will also allow participants to recover natural erectile function.
Locations (4)
St. Vincent's Private Hospital
Fitzroy, Victoria, Australia
Royal Melbourne Hospital
Melbourne, Victoria, Australia
Australian Prostate Centre
North Melbourne, Victoria, Australia
Epworth HealthCare
Richmond, Victoria, Australia